SCHEMBL30487058

SCHEMBL30487058

COC(=O)c1ccc2nc(CC3CCO3)[nH]c2n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ ALDH1A1 P00352 6/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ PDE9A O76083 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ HPGD P15428 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ GLA P06280 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29924789 0.86 HTT (0.36) HTTALDH1A1KMT2AMAPTPDE9A
SCHEMBL30487057 0.86 HTT (0.36) HTTALDH1A1KMT2AMAPTPDE9A
SCHEMBL25435624 0.79 ALDH1A1 (0.51) HTTALDH1A1MAPTLMNAPKM
SCHEMBL9320290 0.78 GABRP (0.40) PTGER4HTTALDH1A1MAPTLMNA
SCHEMBL29262338 0.77 MAPT (0.47) HTTALDH1A1KMT2AMEN1MAPT
SCHEMBL30149296 0.71 GLP1R (0.41) PTGER4HTTALDH1A1KMT2AMEN1
SCHEMBL25543735 0.71 GLP1R (0.41) PTGER4HTTALDH1A1KMT2AMEN1
SCHEMBL29052841 0.70 TSHR (0.38) HTTALDH1A1KMT2APDE9ALMNA
SCHEMBL6301028 0.70 MAPK1 (0.41) PTGER4HTTALDH1A1KMT2AMEN1
SCHEMBL29668755 0.70 DRD4 (0.36) HTTALDH1A1KMT2APDE9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118974037-A Benzobicyclo compound and preparation method and application thereof 广州市联瑞制药有限公司 2024-11-15 — — CN disclosed
Send feedback